Mesenchymal Stem Cell Culture Medium Nicotinamide FGF4

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The challenge lies in efficiently expanding undifferentiated mesenchymal stem cells (MSCs) in culture while maintaining their proliferative potential and differentiation capabilities, as existing methods lead to premature senescence and heterogeneity, making large-scale commercialization of homogenous MSCs difficult due to decreased proliferative potential and increased doubling time during prolonged culture.

Innovation Solution

Culturing MSCs in a medium containing 1-20 mM nicotinamide and 10-100 ng/ml fibroblast growth factor 4 (FGF4) without additional growth factors, with a calcium concentration greater than 1.8 mM, to promote expansion and maintain an undifferentiated state, resulting in a homogeneous and less granular cell population.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If MSCs are cultured in conventional media with multiple growth factors, then cell proliferation is promoted, but cells undergo premature senescence and lose differentiation capacity

Engineering Contradiction:
Improvecell proliferation rateVSAvoiddifferentiation capacity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention changes the chemical parameters of the culture medium by specifying exact concentrations of nicotinamide (1-20 μM) and FGF4 (10-100 ng/ml), while excluding other growth factors. This precise parameter control enables sustained proliferation without senescence, resolving the contradiction between productivity and reliability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention extracts and removes unnecessary growth factors from the culture medium, keeping only nicotinamide and FGF4. This simplification eliminates interfering substances that cause premature senescence, allowing cells to maintain differentiation capacity while proliferating efficiently.

Inventive Principle:
Principle #2Taking out (Extraction)

2Quantity of substance

If MSCs are cultured for prolonged periods to expand population size, then cell quantity increases, but heterogeneity increases and homogeneity decreases

Engineering Contradiction:
Improvecell population sizeVSAvoidcell population homogeneity
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The invention maintains population homogeneity during prolonged culture by controlling medium composition parameters - specifically nicotinamide (1-20 μM) and FGF4 (10-100 ng/ml) concentrations. These parameter controls prevent spontaneous differentiation and maintain uniform cell characteristics even after extensive passage.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention enables continuous useful action by maintaining cells in a stable, undifferentiated state throughout prolonged culture periods. The specific medium composition sustains proliferative potential and prevents senescence, allowing continuous expansion without loss of homogeneity or acquisition of harmful senescent characteristics.

Inventive Principle:
Principle #20Continuity of useful action

3Productivity

If conventional culture methods are used, then initial cell expansion is achieved, but doubling time increases during prolonged culture

Engineering Contradiction:
Improveinitial expansion efficiencyVSAvoidcell division rate
Core Design Contradiction:
ProductivityVSSpeed

Solution Approach 1:

The invention optimizes medium parameters with nicotinamide (1-20 μM) and FGF4 (10-100 ng/ml) to maintain constant doubling time throughout prolonged culture. This parameter control prevents the gradual slowdown in cell division that occurs with conventional methods, sustaining high-speed proliferation.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a dynamic culture system where cells maintain their proliferative potential through controlled exposure to nicotinamide and FGF4. This dynamic approach prevents the progressive loss of division capacity that characterizes conventional static culture methods.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentEP2814951B1Culturing of mesenchymal stem cells
Publication Date: 2019.04.03 GAMIDA CELL
  • EP2814951B1 patent drawingFigure 1
  • EP2814951B1 patent drawingFigure 2A~2B
  • EP2814951B1 patent drawingFigure 3A~3D

AI summary

Methods of culturing mesenchymal stem cells are provided. The methods comprise culturing MSCs in a medium comprising nicotinamide and fibroblast growth factor 4 (FGF4). Populations of mesenchymal stem cells generated using the methods described herein and uses thereof are also provided.